PHOSPH-UBIQ-IMMUN · Dynamic interplay between phosphorylation and ubiquitination during plant receptor kinase-mediated immunity
Horizon 2020 — Marie Skłodowska-Curie Actions
- Duration
- 2017-07-01 → 2019-08-17
- EU contribution
- €195,455
- Participants
- 1
- Scheme
- MSCA-IF-EF-CAR
Lines connect the coordinator with its partners.
Results in brief
Dynamic interplay between phosphorylation and ubiquitination during plant receptor kinase-mediated immunity
The growing population and changing climate challenge the quest for food security. Plant pathogens lead to annual global food production yield losses up to 16-20%. Our travel systems enable pathogens to rapidly spread globally, allowing new diseases to emerge, as shown by the 2016 wheat blast epidemy in Bangladesh, a global food security threat. Thus, plant biologists urgently need to find solutions for existing and emerging diseases. To help plants better protect themselves, we need to know the nature of plant-pathogen interactions and underlying mechanisms of plant immunity by studying how plants respond to pathogen attack, from the moment of recognition of pathogen-associated molecular patterns (PAMPs) to well-orchestrated defense responses. Many PAMPs and their corresponding pattern recognition receptors (PRRs) have been identified, and common principles in activation of PTI have arisen. PAMP-driven interaction of receptor and co-receptor leads to transphosphorylation events resulting in complex activation and phosphorylation of downstream cytoplasmic kinases. The last ones emerged as integrative points of signal transduction, with BIK1 being a key convergent point in signaling triggered by different PAMPs. BIK1 is genetically involved in most PTI outputs, however, many of its downstream targets are still unknown. Prof. Zipfel’s lab recently identified a potential BIK1 phosphorylation motif. A search for this motif in proteins known from the literature to be phosphorylated in response to PAMP treatment, led to the identification of candidate BIK1 substrates. These candidates were verified in a preliminary screen based on the ability of BIK1 to phosphorylate its targets in in vitro kinase assays and to interact with them in planta. Among them, an E3 ubiquitin ligase, which we named BIK1 PHOSPHORYLATION SUBSTRATE 1 (BPS1), was found; as well as two ubiquitin-specific proteases, which we called BPS2 and BPS3. PHOSPH-UBIQ-IMMUN aimed to understand how BIK1 regulates PTI via the characterization of its substrates, thus revealing a dynamic interplay between phosphorylation and ubiquitination events in plant immune signalling. Characterization of key components of immune signalling will ultimately lead to our ability to manipulate them to strengthen plant defense.
Data: CORDIS, © European Union
Project objective
The first layer of plant immunity is mediated by the recognition of conserved microbial features known as pathogen-associated molecular patterns (PAMPs) by plasma membrane-localized pattern recognition receptors (PRRs). An immediate downstream substrate of activated PRR complexes is the cytoplasmic kinase BIK1, which is a positive regulator of PAMP-triggered immunity (PTI). The objective of this proposal is to uncover how BIK1 regulates plant immune signalling via the characterization of its substrates in PTI. The host laboratory has recently identified a potential BIK1 phosphorylation motif, which is present in 22 Arabidopsis proteins that are rapidly phosphorylated upon PAMP treatment. Eight of these proteins have been confirmed as true BIK1 phosphorylation substrates and include several proteins involved in protein ubiquitination/deubiquitination, including an E3 ubiquitin ligase and two ubiquitin specific proteases (USPs), which will be the focus of this study. Preliminary data indicate that the E3 ubiquitin ligase is a positive regulator of PTI. Here, I will further characterize the role of this E3 ubiquitin ligase in PTI by characterising the role of its phosphorylation by BIK1, and identifying its substrates and their role in PTI using genetic and biochemical approaches. A similar approach will be used to decipher the role of the two USPs in PTI. The project will directly benefit from my previous experience in working with deubiquitinating enzymes during plant development, which will provide all the necessary technical and theoretical knowledge to ensure the project’s success. This exciting project will allow me resuming my career in science, thus corresponding to the objectives of the People Work Programme. At the end of the project, we will have a better understanding on how activated PRR complexes regulate downstream immune signalling, which is a very important question in innate immunity, in both plants and mammals.
Original text from CORDIS.
Participants
- THE SAINSBURY LABORATORY · NorwichCoordinatorUnited Kingdom
Links
Data: CORDIS, © European Union
